Type of diabetes and waist-hip ratio are important determinants of serum lipoprotein (a) levels in diabetic patients

Diabetes Research and Clinical Practice

Volumn 56, Issue 3, 2002, Pages 221-227

  Nawawi, Hapizah M ^a   Muhajir, Musilawati ^a   Kian, Yeo Chee ^a   Mohamud, Wan Nazaimoon Wan ^b   Yusoff, Khalid ^a   Khalid, B A K ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Diabetes; Lipoprotein (a); Waist hip ratio

Indexed keywords

ALBUMIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BODY CONSTITUTION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; NORMAL DISTRIBUTION; TRIGLYCERIDES;

EID: 0036204576     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(02)00009-8     Document Type: Article

References (26)

1. Lipoprotein (a) and the risk for myocardial infarction
2. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: dependence on serum LDL levels
3. Lp(a) as a risk factor for myocardial infarction
4. Lipoprotein (a) levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial
5. Dose-response relationship of serum lipid measurements with the extent of coronary stenosis
6. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women: the Framingham Heart Study
7. Diabetes and cardiovascular diseases: the Framingham study
8. Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes
9. Lipoprotein (a) and vascular disease in diabetic patients
10. Lipoprotein(a) and diabetes
11. Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria
12. Lipoprotein(a) as a coronary risk factor in Japanese patients with type 2 (non-insulin-dependent) diabetes mellitus- relation with apolipoprotein (a) phenotypes
13. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients
14. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes
15. Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes
16. Plasma concentrations of lipoprotein (a) and phenotypes in diabetes mellitus
17. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy
18. Is apolipoprotein (a) a susceptibility gene for type 1 diabetes mellitus and related to long-term survival
19. Polymorphisms of apolipoprotein E, lipoprotein(a) and other lipoproteins in children in type 1 diabetes
20. Normal lipoprotein (a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus
21. Age of onset and type of diabetes
22. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians
23. The guidelines on the management of mild hypertension- memorandum from a WHO/ISH meeting
24. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge